Viewing Study NCT00454051


Ignite Creation Date: 2025-12-24 @ 11:54 PM
Ignite Modification Date: 2026-02-01 @ 4:00 AM
Study NCT ID: NCT00454051
Status: COMPLETED
Last Update Posted: 2011-08-08
First Post: 2007-03-28
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Asthma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Asthma, anti-immunoglobulin E, omalizumab, IgE receptors View